PA8506301A1 - CRYSTAL OF 4- CARBOXAMINO- 1,2,3,4, - TETRAHYDROQUINOLINE 2-REPLACED - Google Patents
CRYSTAL OF 4- CARBOXAMINO- 1,2,3,4, - TETRAHYDROQUINOLINE 2-REPLACEDInfo
- Publication number
- PA8506301A1 PA8506301A1 PA20008506301A PA8506301A PA8506301A1 PA 8506301 A1 PA8506301 A1 PA 8506301A1 PA 20008506301 A PA20008506301 A PA 20008506301A PA 8506301 A PA8506301 A PA 8506301A PA 8506301 A1 PA8506301 A1 PA 8506301A1
- Authority
- PA
- Panama
- Prior art keywords
- crystal
- carboxamino
- tetrahydroquinoline
- replaced
- crystals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Abstract
SE DESCRIBEN FORMAS CRISTALINAS DE UN INHIBIDOR DE CETP, PROCEDIMIENTOS PARA PREPARAR LOS CRISTALES, PROCEDIMIENTOS DE USO DE LOS CRISTALES Y COMPOSICIONES FARMACEÚTICAS QUE CONTIENEN LOS CRISTALES.CRYSTAL FORMS OF A CETP INHIBITOR, PROCEDURES TO PREPARE THE CRYSTALS, PROCEDURES FOR USE OF THE CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE CRYSTALS ARE DESCRIBED.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16805199P | 1999-11-30 | 1999-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8506301A1 true PA8506301A1 (en) | 2002-08-26 |
Family
ID=22609901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20008506301A PA8506301A1 (en) | 1999-11-30 | 2000-11-13 | CRYSTAL OF 4- CARBOXAMINO- 1,2,3,4, - TETRAHYDROQUINOLINE 2-REPLACED |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1246804A1 (en) |
JP (1) | JP2003515592A (en) |
KR (1) | KR20020058057A (en) |
CN (1) | CN1402711A (en) |
AP (1) | AP2002002531A0 (en) |
AU (1) | AU1048801A (en) |
BG (1) | BG106854A (en) |
BR (1) | BR0015836A (en) |
CA (1) | CA2392979A1 (en) |
CO (1) | CO5271716A1 (en) |
EA (1) | EA200200510A1 (en) |
EC (1) | ECSP003792A (en) |
EE (1) | EE200200277A (en) |
GT (1) | GT200000199A (en) |
HU (1) | HUP0203521A2 (en) |
IL (1) | IL149097A0 (en) |
IS (1) | IS6338A (en) |
MA (1) | MA26845A1 (en) |
MX (1) | MXPA02005354A (en) |
NO (1) | NO20022558D0 (en) |
OA (1) | OA12099A (en) |
PA (1) | PA8506301A1 (en) |
PE (1) | PE20010904A1 (en) |
PL (1) | PL355892A1 (en) |
TN (1) | TNSN00231A1 (en) |
TR (1) | TR200201446T2 (en) |
UY (1) | UY26454A1 (en) |
WO (1) | WO2001040190A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
OA12619A (en) * | 2001-06-21 | 2006-06-12 | Pfizer Prod Inc | Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors. |
GT200200170A (en) | 2001-09-28 | 2003-05-23 | PREPARATION OF INHIBITOR OF CETP ANHIDRO | |
CA2474838C (en) | 2002-02-01 | 2009-01-06 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
MXPA04007433A (en) * | 2002-02-01 | 2004-10-11 | Pfizer Prod Inc | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus. |
EP1920766B1 (en) * | 2002-02-01 | 2017-08-23 | Bend Research, Inc | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
DK1533292T3 (en) | 2002-08-30 | 2007-06-04 | Japan Tobacco Inc | Dibenzylamine compound and its medical use |
US7504508B2 (en) | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
AU2003277285B2 (en) | 2002-10-04 | 2007-12-13 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
AU2003283769A1 (en) | 2002-12-20 | 2004-07-14 | Pfizer Products Inc. | Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
EA200501376A1 (en) * | 2003-03-28 | 2006-04-28 | Пфайзер Продактс Инк. | DERIVATIVES OF 1,2,4-SUBSTITUTED 1,2,3,4-TETRAHYDRO- and 1,2-DIHYDROCHINOLINES AND 1,2,3,4-TETRAHYDROCHINOXALINE AS AN INHIBITORS CETR FOR THE TREATMENT OF ATHEROSCLEROSIS AND FAT |
ATE540671T1 (en) | 2003-08-04 | 2012-01-15 | Bend Res Inc | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DRUG ADSORBATES AND LIPOPHILIC MICROPHASE-FORMING MATERIALS |
MXPA06003927A (en) | 2003-10-08 | 2008-02-07 | Lilly Co Eli | Compounds and methods for treating dyslipidemia. |
WO2005100298A1 (en) * | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Cetp inhibitors |
WO2006012093A1 (en) * | 2004-06-24 | 2006-02-02 | Eli Lilly And Company | Compounds and methods for treating dyslipidemia |
US20070149567A1 (en) * | 2004-09-23 | 2007-06-28 | Pfizer Inc | Quinoline compounds |
WO2006033001A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Quinoline compounds |
KR20070114762A (en) | 2005-02-24 | 2007-12-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
WO2006098394A1 (en) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | Method for inhibiting lipid absorption and lipid absorption inhibitor |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
EP2134169A2 (en) | 2007-03-09 | 2009-12-23 | Indigene Pharmaceuticals Inc. | Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
WO2010075069A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
WO2010075068A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
AR077208A1 (en) | 2009-06-30 | 2011-08-10 | Lilly Co Eli | ACID DERIVATIVES TRANS-4 - [[(5S) -5 - [[[3,5-BIS (TRIFLUOROMETIL) PHENYLE] METHYL] (2-METHYL-2H-TETRAZOL-5-IL) AMINO) -2,3, 4,5-TETRAHIDRO-7,9-DIMETIL-1H-1-BENZAZEPIN-1-IL) METHYL) -CYCLHEXANCARBOXYL AND ITS CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT, ITS USE TO PREPARE A MEDICAM |
WO2016016157A1 (en) | 2014-07-30 | 2016-02-04 | F. Hoffmann-La Roche Ag | Genetic markers for predicting responsiveness to therapy with hdl-raising or hdl mimicking agent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231102A (en) * | 1989-03-08 | 1993-07-27 | Merck Sharp & Dohme, Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
WO1998033775A1 (en) * | 1997-02-03 | 1998-08-06 | American Home Products Corporation | 2-substituted-1-acyl-1,2-dihydroquinoline derivatives to increase hdl-cholesterol level |
US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
-
2000
- 2000-11-09 CO CO00085285A patent/CO5271716A1/en unknown
- 2000-11-13 PA PA20008506301A patent/PA8506301A1/en unknown
- 2000-11-14 JP JP2001541875A patent/JP2003515592A/en active Pending
- 2000-11-14 EP EP00971662A patent/EP1246804A1/en not_active Withdrawn
- 2000-11-14 PL PL00355892A patent/PL355892A1/en not_active Application Discontinuation
- 2000-11-14 WO PCT/IB2000/001650 patent/WO2001040190A1/en not_active Application Discontinuation
- 2000-11-14 HU HU0203521A patent/HUP0203521A2/en unknown
- 2000-11-14 TR TR2002/01446T patent/TR200201446T2/en unknown
- 2000-11-14 OA OA1200200158A patent/OA12099A/en unknown
- 2000-11-14 EE EEP200200277A patent/EE200200277A/en unknown
- 2000-11-14 KR KR1020027006914A patent/KR20020058057A/en not_active Application Discontinuation
- 2000-11-14 CN CN00816463A patent/CN1402711A/en active Pending
- 2000-11-14 EA EA200200510A patent/EA200200510A1/en unknown
- 2000-11-14 BR BR0015836-4A patent/BR0015836A/en not_active IP Right Cessation
- 2000-11-14 MX MXPA02005354A patent/MXPA02005354A/en unknown
- 2000-11-14 CA CA002392979A patent/CA2392979A1/en not_active Abandoned
- 2000-11-14 AP APAP/P/2002/002531A patent/AP2002002531A0/en unknown
- 2000-11-14 IL IL14909700A patent/IL149097A0/en unknown
- 2000-11-14 AU AU10488/01A patent/AU1048801A/en not_active Abandoned
- 2000-11-28 PE PE2000001267A patent/PE20010904A1/en not_active Application Discontinuation
- 2000-11-28 UY UY26454A patent/UY26454A1/en not_active Application Discontinuation
- 2000-11-29 TN TNTNSN00231A patent/TNSN00231A1/en unknown
- 2000-11-29 GT GT200000199A patent/GT200000199A/en unknown
- 2000-11-29 EC EC2000003792A patent/ECSP003792A/en unknown
-
2002
- 2002-04-12 IS IS6338A patent/IS6338A/en unknown
- 2002-05-27 MA MA26653A patent/MA26845A1/en unknown
- 2002-05-29 NO NO20022558A patent/NO20022558D0/en not_active Application Discontinuation
- 2002-06-20 BG BG106854A patent/BG106854A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0015836A (en) | 2002-08-06 |
WO2001040190A1 (en) | 2001-06-07 |
EE200200277A (en) | 2003-10-15 |
IL149097A0 (en) | 2002-11-10 |
AP2002002531A0 (en) | 2002-06-30 |
KR20020058057A (en) | 2002-07-12 |
ECSP003792A (en) | 2002-04-23 |
BG106854A (en) | 2002-12-29 |
AU1048801A (en) | 2001-06-12 |
PE20010904A1 (en) | 2001-09-10 |
MA26845A1 (en) | 2004-12-20 |
CO5271716A1 (en) | 2003-04-30 |
HUP0203521A2 (en) | 2003-02-28 |
CN1402711A (en) | 2003-03-12 |
OA12099A (en) | 2006-05-04 |
NO20022558L (en) | 2002-05-29 |
UY26454A1 (en) | 2001-07-31 |
JP2003515592A (en) | 2003-05-07 |
TNSN00231A1 (en) | 2002-05-30 |
MXPA02005354A (en) | 2002-12-11 |
GT200000199A (en) | 2002-05-23 |
EP1246804A1 (en) | 2002-10-09 |
TR200201446T2 (en) | 2002-11-21 |
NO20022558D0 (en) | 2002-05-29 |
PL355892A1 (en) | 2004-05-31 |
CA2392979A1 (en) | 2001-06-07 |
IS6338A (en) | 2002-04-12 |
EA200200510A1 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8506301A1 (en) | CRYSTAL OF 4- CARBOXAMINO- 1,2,3,4, - TETRAHYDROQUINOLINE 2-REPLACED | |
BR0111667A (en) | New compounds | |
HN2002000275A (en) | DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | |
AR011069A1 (en) | AMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL FORMULATIONS THAT UNDERSTAND THEM, AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AS AN INHIBITOR OF NITRIC OXIDE, INDUCIBLE SYNTHESES. | |
ES2090713T3 (en) | ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE. | |
UY24555A1 (en) | NEW COMPOUNDS | |
GT199900102A (en) | PHENOXIPROPANOLAMINES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
MX9102501A (en) | METHANE SULFONAMIDE DERIVATIVES, FARDERIVED COMPOSITIONS OF METHANOSULFONAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURE FOR SMACEUTICS THAT CONTAIN THEM AND PROCEDURE FOR U PREPARATION. ITS PREPARATION. | |
AR015349A1 (en) | NEW CRYSTAL MODIFICATIONS OF 2-AMINO-4- (4-FLUORBENCILAMINE) -1-ETOXICARBONIL-AMINOBENCENO AND PROCEDURE TO PREPARE THEM, USE OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM | |
HN2002000300A (en) | NEW DERIVATIVES OF PIPERAZINA | |
ES2157993T3 (en) | BENZOILGUANIDINAS, ITS PREPARATION AND ITS USE IN MEDICINES. | |
ES2178055T3 (en) | SUBSTITUTED AMINIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
DK0929565T3 (en) | Nitrate esters of corticoid compounds and their pharmaceutical applications | |
ES2134801T3 (en) | CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE. | |
PA8586801A1 (en) | HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | |
NO934628L (en) | Retroviral protease inhibitors | |
HN2001000235A (en) | DERIVATIVES BRIDGES OF PIPERAZINA | |
ECSP034531A (en) | SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA | |
DK1051177T3 (en) | Steroidal 3-O-Sulfamate derivatives as inhibitors of oestrone sulfatase | |
AR020563A1 (en) | TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE | |
MX9303572A (en) | PROTEASE INHIBITORS OF THE HUMAN IMMUNODEFICIENCY SYNDROME, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM. | |
CR6398A (en) | 5HT1 ANTAGONISTS FOR ANTIDEPRESSIVE THERAPY | |
ES2186989T3 (en) | MALTITOL CRYSTALS OF SPECIFIC FORMS, CRYSTAL COMPOUNDS THAT CONTAIN THEM AND PROCEDURES FOR THEIR PREPARATION. | |
PA8495001A1 (en) | NEW CRYSTAL FORMS OF AN ANTIBIOTIC MACROLIDO. | |
AR002017A1 (en) | DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE. |